2.71
price down icon1.45%   -0.04
after-market Dopo l'orario di chiusura: 2.71
loading

Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - 26.86 -
Operating Expenses
6.45%
33.73
36.06 45.62 76.71 51.43
Operating Income/Loss
6.45%
-33.73
-36.06 -45.62 -49.85 -51.43
Income/Loss From Continuing Operations Before Tax
0.68%
-26.69
-26.87 -48.28 -47.68 -40.19
Income Tax Expense/Benefit
-
- - -0.205 -0.027
Income/Loss From Continuing Operations After Tax
0.68%
-26.69
-26.87 -48.28 -47.47 -40.16
Net Income/Loss
0.68%
-26.69
-26.87 -48.28 -47.47 -40.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.20%
72.14
71.99 71.68 0.063 71.11
Diluted Average Shares
0.20%
72.14
71.99 71.68 0.063 71.11
Basic Earnings Per Share
0.00%
-0.37
-0.37 -0.67 -0.66 -0.56
Diluted Earnings Per Share
0.00%
-0.37
-0.37 -0.67 -0.66 -0.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):